Mene Pangalos, AstraZeneca’s departing R&D chief
August 10, 2023 09:50 AM EDT
People
R&D
Pharma

Ex­clu­sive: As­traZeneca’s out­go­ing R&D chief Mene Pan­ga­los re­flects on a 14-year R&D turn­around and the in­dus­try's fu­ture

Andrew Dunn

Senior Biopharma Correspondent

When As­traZeneca R&D ex­ec­u­tive Mene Pan­ga­los joined the com­pa­ny in 2010, the UK drug gi­ant was fac­ing ex­is­ten­tial threats: shrink­ing sales …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times